ArticleJournal of cachexia, sarcopenia and muscle2026
Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma-Associated Cachexia.
Article in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCachexia in oesophageal squamous cell carcinoma is driven by systemic inflammation and malnutrition and is associated with poor survival. We evaluated whether circulating miRNAs can identify ESCC cachexia and reflect its inflammatory-nutritional phenotype.
methodsWe enrolled 126 participants: 42 healthy controls and 84 treatment-naïve patients with ESCC, equally classified as noncachectic or cachectic using international consensus criteria. Small-RNA sequencing in a discovery subset (n = 4/group) was followed by cohort-wide qRT-PCR. Exploratory within-cohort discrimination was assessed by receiver operating characteristic (ROC) analysis; survival associations were evaluated using Kaplan-Meier and univariate Cox analyses.
resultsCachectic ESCC was characterized by lower albumin, total protein and prealbumin and higher IL-6, TNF-α, CRP and IL-1β than noncachectic ESCC (all p < 0.05). Circulating hsa-miR-5187-5p and hsa-miR-4433b-3p increased stepwise from controls to noncachectic and cachectic ESCC. For noncachectic versus cachectic ESCC, AUCs were 0.8594 and 0.8175, respectively (both p < 0.0001); for controls versus cachectic ESCC, AUCs were 0.9439 and 0.8889. Cachexia was associated with shorter overall survival (HR 1.708, 95% CI 1.011-2.887; p = 0.026), as were high miR-5187-5p (HR 3.635) and miR-4433b-3p (HR 3.190) expression. Correlations with inflammatory markers and albumin were weak to moderate.
conclusionshsa-miR-5187-5p and hsa-miR-4433b-3p are candidate circulating indicators of ESCC-associated cachexia and its inflammatory-metabolic milieu. Their discriminatory and prognostic performance remains exploratory because analyses were conducted within the same cohort and were not comprehensively adjusted for tumour stage or other clinicopathological factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.